magnesium diasporal 295,7 mg granulas iekšķīgi lietojama šķīduma pagatavošanai
protina pharmazeutische gesellschaft mbh, germany - magnijs - granulas iekšķīgi lietojama šķīduma pagatavošanai - 295,7 mg
magnesium diasporal direct 400 mg granulas paciņā
protina pharmazeutische gmbh, germany - magnijs - granulas paciņā - 400 mg
magnesium diasporal 400 mg pulveris iekšķīgi lietojama šķīduma pagatavošanai
protina pharmazeutische gmbh, germany - magnijs - pulveris iekšķīgi lietojama šķīduma pagatavošanai - 400 mg
basica® compact (paziņots 2011.) tablete
protina pharm. gmbh - tablete
basica vital® pur (2018.) pulveris
protina pharm. gmbh - pulveris
magnesium diasporal 400 extra direkt (paziņots 2015.) cits, granulas
protina pharm. gmbh - cits, granulas
basica® direkt (paziņots 2011.) pulveris
protina pharm. gmbh - pulveris
magnesium diasporal® 300 direkt (paziņots) cits, granulas
protina pharmazeutische gesellschaft gmbh - cits, granulas
magnesium diasporal® 300 (paziņots) granulas
protina pharmazeutische gesellschaft mbh - granulas
hizentra
csl behring gmbh - cilvēka normālais imūnglobulīns (scig) - imūndeficīta sindromi - un imūnglobulīni, - replacement therapy in adults, children and adolescents (0-18 years) in:- primary immunodeficiency syndromes with impaired antibody production (see section 4. - secondary immunodeficiencies (sid) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (psaf)* or serum igg level of.